AU4251197A - Therapeutic chemokine antagonists - Google Patents

Therapeutic chemokine antagonists

Info

Publication number
AU4251197A
AU4251197A AU42511/97A AU4251197A AU4251197A AU 4251197 A AU4251197 A AU 4251197A AU 42511/97 A AU42511/97 A AU 42511/97A AU 4251197 A AU4251197 A AU 4251197A AU 4251197 A AU4251197 A AU 4251197A
Authority
AU
Australia
Prior art keywords
chemokine antagonists
therapeutic
therapeutic chemokine
antagonists
chemokine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42511/97A
Inventor
Larry O Arthur
Oleg Y. Chertov
Joost J Oppenheim
Ji Ming Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU4251197A publication Critical patent/AU4251197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU42511/97A 1996-09-06 1997-09-05 Therapeutic chemokine antagonists Abandoned AU4251197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2470896P 1996-09-06 1996-09-06
US60024708 1996-09-06
PCT/US1997/015594 WO1998009642A2 (en) 1996-09-06 1997-09-05 Therapeutic chemokine antagonists

Publications (1)

Publication Number Publication Date
AU4251197A true AU4251197A (en) 1998-03-26

Family

ID=21821982

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42511/97A Abandoned AU4251197A (en) 1996-09-06 1997-09-05 Therapeutic chemokine antagonists

Country Status (2)

Country Link
AU (1) AU4251197A (en)
WO (1) WO1998009642A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU762472B2 (en) 1998-03-13 2003-06-26 University Of British Columbia, The Therapeutic chemokine receptor antagonists
WO2000009152A1 (en) * 1998-08-14 2000-02-24 The University Of British Columbia Therapeutic chemokine receptor antagonists
CA2305787A1 (en) 2000-05-09 2001-11-09 The University Of British Columbia Cxcr4 antagonist treatment of hematopoietic cells
CA2245224A1 (en) 1998-08-14 2000-02-14 Jiang-Hong Giong Chemokine receptor antagonists and chemotherapeutics
EP1066047A4 (en) * 1998-03-25 2004-10-13 Mayo Foundation For Medicaledu Methods and materials for treating inflammatory diseases
EP1100527A2 (en) 1998-06-01 2001-05-23 University Of Maryland Biotechnology Institute Receptor ligand antagonist complexes and their use in treating or preventing receptor mediated diseases
WO1999065507A1 (en) * 1998-06-19 1999-12-23 The General Hospital Corporation Modulating platelet function
JP2002535358A (en) * 1999-01-29 2002-10-22 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Methods for preventing graft rejection and ischemia-reperfusion injury
AU4230900A (en) * 1999-04-08 2000-10-23 General Hospital Corporation, The Purposeful movement of human migratory cells away from an agent source
US20050059584A1 (en) 2002-08-16 2005-03-17 Ahmed Merzouk Novel chemokine mimetics synthesis and their use
US7368425B2 (en) 2006-03-24 2008-05-06 Chemokine Therapeutics Corp. Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
US7378098B2 (en) 2000-04-12 2008-05-27 The University Of British Columbia CXC chemokine receptor 4 agonist peptides
CA2586765A1 (en) 2004-11-05 2006-12-28 The General Hospital Corporation Purposeful movement of human migratory cells away from an agent source
EP1674077A1 (en) * 2004-12-27 2006-06-28 Université de Liège Mucoadhesive pharmaceutical compositions comprising chemoattractants
AU2017370942A1 (en) 2016-12-07 2019-06-13 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
WO2018112264A1 (en) 2016-12-14 2018-06-21 Progenity Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
US20220249814A1 (en) 2018-11-19 2022-08-11 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
EP4309722A2 (en) 2019-12-13 2024-01-24 Biora Therapeutics, Inc. Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2160696C (en) * 1993-04-16 2004-08-03 Anders Vahlne Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission

Also Published As

Publication number Publication date
WO1998009642A2 (en) 1998-03-12
WO1998009642A3 (en) 1998-07-09

Similar Documents

Publication Publication Date Title
AU3633997A (en) Chemokine receptor antagonists
AU5274499A (en) Therapeutic chemokine receptor antagonists
AUPO203996A0 (en) Therapeutic uses
AU3899997A (en) Muscarinic antagonists
AU2524995A (en) Neurokinine (tachykinine) antagonists
AU3043997A (en) Electrotherapy device
AU3288897A (en) Chair construction
AU1842995A (en) N-acylpiperidine tachykinin antagonists
EP0825096A3 (en) Body construction
AU4343796A (en) Tachykinin antagonists
AU7645496A (en) Roundsling construction
AU4251197A (en) Therapeutic chemokine antagonists
AU8495998A (en) Improved dosage units
AU6856796A (en) Des-arg9-bk antagonists
AU6447998A (en) Human chemokine receptor-like chemokine
AU5383498A (en) Human chemokine beta-13
AU5355996A (en) Human chemokine polypeptides
AUPO434196A0 (en) An improved therapeutic
AU1769497A (en) Modified cytokines for therapeutic use
AU2698795A (en) Human chemokine beta-12
EP0904287A3 (en) Cytokine designated lerk-8
AU7583998A (en) Human chemokine zchemo-8
AU3852997A (en) Phenoxypropanolamines having beta3-adrenergic antagonist activity
AU5308998A (en) Dispersoid-reinforced electrode
AU5425496A (en) Chemokine alpha 3